Satisfaction

Satisfaction study

Dear client,
In order to evaluate and constantly improve the quality of our projects, we would like to obtain your opinion concerning the conception and roll-out of your project.
We therefore invite you to evaluate the following topics on a scale of 0 to 10, (0 meaning “no, not at all” and 10 meaning “yes, precisely”):

To send us your evaluation, thanks to fill-in the following information:

Last name *

First name *

E-mail *

Company

Project name

1. Did the project achieve its objectives? *

2. Was the approach consistent with your needs? *

3. Are you satisfied with the project quality? *

4. Did you have a positive experience interacting witht the Observia team? *

5. Did the team respect the timing? *

6. Would you recommend Observia to one of your colleagues? *

7. Can we quote your name as a client reference? *

Yes

No

8. Can we use this project to communicate (without disclosing the company name)? *

Yes

No

Lastly, here are three open-ended questions to find out a bit more concerning your perception of Observia and our different areas of improvement:

How has your perception of Observia evolved?

What do you consider Observia's main strengths?

What can we improve ?

* I agree with Observia's GDPR

We are processing this data per your request only. We are hosting the data internally. We will not share it.

Here’s a link to our privacy policy. You can find out how to send a request to access your data, request to delete your data, correct any inaccuracies or restrict our processing of your data.

You have the right to lodge a complaint about the way we handle your data with French Data Protection authority CNIL or you can contact our DPO at contact form for more information or with concerns.

Satisfaction

Satisfaction study

To send us your evaluation, thanks to fill-in the following information:

Lastly, here are three open-ended questions to find out a bit more concerning your perception of Observia and our different areas of improvement:

Improve patients' lives

Observia

A multiple-cohort analysis of the SPUR 6/24 patient-reported adherence tool

Observia at Reuters Pharma